Medicine and Dentistry
Neoplasm
100%
Patient
85%
Overall Survival
83%
Chemoradiotherapy
74%
Tomotherapy
65%
Stereotactic Body Radiation Therapy
65%
Recurrent Disease
62%
Intensity Modulated Radiation Therapy
55%
Therapeutic Procedure
50%
Rectum Cancer
46%
Radiation Therapy
43%
Hepatocellular Carcinoma
42%
Adjuvant Chemotherapy
42%
Non Small Cell Lung Cancer
40%
Total Mesorectal Excision
35%
Wart Virus
33%
Surgery
32%
Arm
29%
Toxicity
29%
Drug Megadose
29%
Prostate Cancer
27%
Surgical Margin
27%
Stereotactic Radiosurgery
25%
Analysis
24%
Survival Rate
24%
Recurrence Free Survival
24%
Hypofractionated Radiotherapy
24%
Meta-Analysis
24%
Child-Pugh Score
23%
Glioblastoma
23%
Positron Emission Tomography
23%
Perineural Invasion
23%
Neck
22%
Lymph Node
22%
Progression Free Survival
21%
Propensity Score Matching
21%
Disease Free Survival
20%
Survival
19%
Subgroup Analysis
17%
Inpatient
17%
Laryngeal Cancer
17%
Retrospective Study
17%
Chemotherapy
17%
Distant Metastasis
15%
Breast Cancer
15%
Prognostic Factor
14%
Metastatic Carcinoma
14%
Liver Function
14%
Optimal Drug Dose
13%
Head and Neck Cancer
13%
Pharmacology, Toxicology and Pharmaceutical Science
Overall Survival
64%
Neoplasm
45%
Recurrent Disease
34%
Disease Free Survival
24%
Non Small Cell Lung Cancer
23%
Prostate Cancer
20%
Retrospective Study
18%
Liver Cell Carcinoma
17%
Human Papillomavirus
17%
Chemoradiation Therapy
17%
Progression Free Survival
16%
Survival Rate
15%
Distant Metastasis
13%
Chemotherapy
13%
Acute Toxicity
12%
Oropharynx Cancer
11%
Intracranial Tumor
11%
Colorectal Carcinoma
11%
Larynx Cancer
11%
Overall Survival
9%
Randomized Controlled Trial
8%
Radiation Pneumonia
8%
Lung Cancer
6%
Remission
6%
Head and Neck Cancer
6%
Survival
6%
Radiation
6%
Brain Metastasis
5%
Alpha-Lipoic Acid
5%
Intestine Injury
5%
Vaginal Intraepithelial Neoplasia
5%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
5%
Lung Nodule
5%
Radiation Pneumonia
5%
Lung Tumor
5%
Distant Metastasis
5%
Fluorouracil
5%
Head and Neck Squamous Cell Carcinoma
5%
Primary Central Nervous System Lymphoma
5%
Diffuse Large B Cell Lymphoma
5%
Marginal Zone Lymphoma
5%
Clinical Study
5%
Prostate Specific Antigen
5%
Squamous Cell Carcinoma
5%
Oxaliplatin
5%
Non Small Cell Lung Cancer
5%
Female Genital Tract Cancer
5%
Local Recurrence Free Survival
5%
Pneumonia
5%
Oxaliplatin
5%